Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetrotide pretreatment in poor responders undergoing IVF
IRCT20190602043792N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cetrorelix in female infertility (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Number of oocytes retrieved. Started Aug 2019; status: completed.
02
Drugs
cetrorelix
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20190602043792N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190602043792N1.